ImmuPharma PLC has announced that it has agreed with Incanthera plc to extend the warrants issued to the company by 12 months. The warrants were originally issued in February 2020 and allowed ImmuPharma to subscribe for 7,272,740 ordinary shares in Incanthera. The extension means that the warrants will now be valid until September 6, 2024. ImmuPharma currently owns 9,904,319 shares in Incanthera, representing 12.7% of its issued share capital. The extension of the warrants is being treated as a related party transaction, and the board of ImmuPharma has determined that the terms of the extension are fair and reasonable.